| Therapeutic options for management of endometrial hyperplasia V Chandra, JJ Kim, DM Benbrook, A Dwivedi, R Rai Journal of gynecologic oncology 27 (1), 2016 | 290 | 2016 |
| Phylogeography of mtDNA haplogroup R7 in the Indian peninsula G Chaubey, M Karmin, E Metspalu, M Metspalu, D Selvi-Rani, VK Singh, ... BMC Evolutionary Biology 8 (1), 1-12, 2008 | 71 | 2008 |
| (−)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation M Manohar, I Fatima, R Saxena, V Chandra, PL Sankhwar, A Dwivedi The Journal of nutritional biochemistry 24 (6), 940-947, 2013 | 69 | 2013 |
| Synthesis and biological evaluation of 3, 4, 6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents R Shankar, B Chakravarti, US Singh, MI Ansari, S Deshpande, ... Bioorganic & medicinal chemistry 17 (11), 3847-3856, 2009 | 65 | 2009 |
| MicroRNA aberrations: An emerging field for gallbladder cancer management V Chandra, JJ Kim, B Mittal, R Rai World Journal of Gastroenterology 22 (5), 1787, 2016 | 54 | 2016 |
| Inhibitory effect of 2-(piperidinoethoxyphenyl)-3-(4-hydroxyphenyl)-2H-benzo (b) pyran (K-1) on human primary endometrial hyperplasial cells mediated via combined suppression … V Chandra, I Fatima, M Manohar, P Popli, VK Sirohi, MK Hussain, ... Cell death & disease 5 (8), e1380-e1380, 2014 | 44 | 2014 |
| Targeting Wnt signaling in endometrial cancer I Fatima, S Barman, R Rai, KW Thiel, V Chandra Cancers 13 (10), 2351, 2021 | 41 | 2021 |
| Synthesis and biological evaluation of 2, 3, 4-triarylbenzopyran derivatives as SERM and therapeutic agent for breast cancer S Kumar, S Deshpande, V Chandra, S Kitchlu, A Dwivedi, VL Nayak, ... Bioorganic & medicinal chemistry 17 (19), 6832-6840, 2009 | 36 | 2009 |
| Phytoestrogen genistein inhibits EGFR/PI3K/NF-kB activation and induces apoptosis in human endometrial hyperplasial cells V Shukla, V Chandra, P Sankhwar, P Popli, JB Kaushal, VK Sirohi, ... Rsc Advances 5 (69), 56075-56085, 2015 | 31 | 2015 |
| Cholecystokinin and gastrin receptors targeting in gastrointestinal cancer R Rai, V Chandra, M Tewari, M Kumar, HS Shukla Surgical oncology 21 (4), 281-292, 2012 | 27 | 2012 |
| Chromatin CKAP2, a new proliferation marker, as independent prognostic indicator in breast cancer HS Kim, JS Koh, YB Choi, J Ro, HK Kim, MK Kim, BH Nam, KT Kim, ... PloS one 9 (6), e98160, 2014 | 25 | 2014 |
| Preclinical Efficacy and Involvement of AKT, mTOR, and ERK Kinases in the Mechanism of Sulforaphane against Endometrial Cancer R Rajani, GE Kathleen, MB Doris, G Justin, DZ Yan, C Vishal Cancers 12 ((5)), 1273, 2020 | 23 | 2020 |
| Ormeloxifene inhibits osteoclast differentiation in parallel to downregulating RANKL-induced ROS generation and suppressing the activation of ERK and JNK in murine RAW264. 7 cells G Kharkwal, V Chandra, I Fatima, A Dwivedi Journal of molecular endocrinology 48 (3), 261-270, 2012 | 22 | 2012 |
| Ghost probiotics with a combined regimen: A novel therapeutic approach against the Zika virus, an emerging world threat VK Bajpai, V Chandra, NH Kim, R Rai, P Kumar, K Kim, A Aeron, SC Kang, ... Critical reviews in biotechnology 38 (3), 438-454, 2018 | 19 | 2018 |
| 2, 3-Diaryl-2H-1-benzopyran derivatives interfere with classical and non-classical estrogen receptor signaling pathways, inhibit Akt activation and induce apoptosis in human … I Fatima, V Chandra, R Saxena, M Manohar, Y Sanghani, K Hajela, ... Molecular and cellular endocrinology 348 (1), 198-210, 2012 | 19 | 2012 |
| Optimization of a vaginal suppository formulation to deliver SHetA2 as a novel treatment for cervical dysplasia S Mahjabeen, MK Hatipoglu, V Chandra, DM Benbrook, ... Journal of pharmaceutical sciences 107 (2), 638-646, 2018 | 16 | 2018 |
| Apoptosis induction and inhibition of hyperplasia formation by 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo (b) pyran in rat uterus V Chandra, I Fatima, R Saxena, S Kitchlu, S Sharma, MK Hussain, ... American Journal of Obstetrics and Gynecology 205 (4), 362. e1-362. e11, 2011 | 15 | 2011 |
| Utility and mechanism of Sheta2 and paclitaxel for treatment of endometrial cancer V Chandra, R Rai, DM Benbrook Cancers 13 (10), 2322, 2021 | 14 | 2021 |
| Impact of DCC (rs714) and PSCA (rs2294008 and rs2976392) Gene Polymorphism in Modulating Cancer Risk in Asian Population V Chandra, JJ Kim, U Gupta, B Mittal, R Rai Genes 7 (2), 9, 2016 | 14 | 2016 |
| Effects of deranged metabolism on epigenetic changes in cancer V Chandra, KM Hong Archives of Pharmacal Research 38, 321-337, 2015 | 12 | 2015 |
Dr. Rajani RaiOklahoma UniversityVerified email at ouhsc.edu
